Swollen neurons that contain numerous lysosomes filled with lipid are typical of
First, the core concept here is lysosomal storage diseases. These are genetic disorders where the body can't break down certain materials due to enzyme deficiencies, leading to accumulation in lysosomes. Tay-Sachs is a classic example caused by a deficiency in hexosaminidase A, which leads to GM2 ganglioside accumulation in neurons. The accumulation causes the neurons to swell and become packed with lipid-laden lysosomes, which is what the question is describing.
Now, why is Tay-Sachs the right answer? The key here is the specific enzyme deficiency and the substrate that builds up. Hexosaminidase A normally breaks down GM2 gangliosides. Without it, these lipids accumulate in the lysosomes of neurons, causing them to swell. This leads to the characteristic "tay-sachs cells" or "neuronal ballooning" seen in the disease. The clinical presentation typically includes progressive neurodegeneration in infants, which aligns with the pathophysiology.
Looking at the other options, Niemann-Pick disease is caused by sphingomyelinase deficiency, leading to sphingomyelin accumulation. The cells there might show "foam cells" in the spleen and liver. Krabbe disease involves galactocerebrosidase deficiency, causing galactocerebroside buildup, which affects myelin sheaths. Gaucher disease is due to glucocerebrosidase deficiency, leading to glucocerebroside accumulation, primarily in the liver and spleen, not the neurons. Each of these has different substrates and affected organs, so they don't fit the neuronal lipid-laden lysosomes described here.
The clinical pearl here is to remember that Tay-Sachs is a lysosomal storage disease with a specific enzyme deficiency leading to GM2 ganglioside accumulation in neurons. The key features are early-onset neurodegeneration and the presence of lipid-laden neurons. It's important to differentiate it from other storage diseases based on the enzyme and substrate involved.
So putting it all together, the correct answer is Tay-Sachs disease. The other options don't fit the described pathology. The clinical pearl helps in remembering the key features and differentiating it from similar conditions.
**Core Concept**
This question tests knowledge of **lysosomal storage diseases**, specifically **Tay-Sachs disease**, which results from **hexosaminidase A deficiency**. The pathognomonic feature is **GM2 ganglioside accumulation** in neurons, leading to **lysosomal lipid accumulation** and **neuronal swelling**.
**Why the Correct Answer is Right**
Tay-Sachs disease is an autosomal recessive disorder caused by **hexosaminidase A deficiency**, preventing the breakdown of **GM2 gangliosides**. These lipids accumulate in **lysosomes of neurons**, causing **neuronal swelling** and **lipid-filled lysosomes**. The disease presents in infancy with **progressive neurodegeneration**, **cherry-red macula**, and **early death** due to uncontrolled substrate accumulation.
**Why Each Wrong Option is Incorrect**
**Option A:** *Niemann-Pick disease* involves **